PapersFlow Research Brief
Trauma, Hemostasis, Coagulopathy, Resuscitation
Research Guide
What is Trauma, Hemostasis, Coagulopathy, Resuscitation?
Trauma, Hemostasis, Coagulopathy, Resuscitation refers to the clinical management of bleeding disorders, clotting processes, and fluid replacement strategies in trauma patients to prevent death from hemorrhage and improve outcomes in critical care.
This field encompasses 44,052 published works on fluid resuscitation, coagulopathy correction, and hemorrhage control in trauma settings using agents like albumin, crystalloids, and tranexamic acid. Key methods include thromboelastography for assessing coagulation and balanced transfusion ratios such as 1:1:1 for plasma, platelets, and red blood cells. Studies demonstrate that restrictive red-cell transfusion strategies match or exceed liberal approaches in critically ill patients, except possibly those with acute myocardial infarction.
Topic Hierarchy
Research Sub-Topics
Trauma-Induced Coagulopathy
This sub-topic investigates acute coagulopathy mechanisms involving tissue factor, TMEM16F, and ADAMTS13. Researchers correlate biomarkers like syndecan-1 with outcomes using TEG/ROTEM.
Damage Control Resuscitation
This sub-topic evaluates 1:1:1 transfusion ratios, tranexamic acid timing, and permissive hypotension. Researchers analyze RCTs on survival and organ failure in hemorrhagic shock.
Thromboelastography Trauma
This sub-topic validates TEG/ROTEM for guiding transfusion, detecting hyperfibrinolysis, and monitoring therapy. Researchers develop algorithms integrating platelet mapping and functional fibrinogen.
Glycocalyx Degradation Hemorrhage
This sub-topic examines heparan sulfate shedding in shock, endothelial dysfunction, and edema formation. Researchers test protective agents like sulodexide in animal models and humans.
Fluid Resuscitation Strategies Sepsis
This sub-topic compares balanced crystalloids, albumin, and colloids in sepsis bundles per Surviving Sepsis guidelines. Researchers assess AKI risk, fluid overload, and dynamic responsiveness measures.
Why It Matters
In trauma care, effective hemostasis and resuscitation directly reduce mortality from massive hemorrhage, as shown in the PROPPR trial where a 1:1:1 transfusion ratio of plasma, platelets, and red blood cells yielded 9.2% mortality at 24 hours and 21.2% at 30 days compared to 1:1:2 ratios in severe trauma patients (Holcomb et al., 2015, "Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma"). Tranexamic acid administration lowers death, vascular occlusive events, and transfusion needs in patients with significant hemorrhage (Williams-Johnson et al., 2010, "Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial"). Albumin and saline produce equivalent 28-day outcomes in ICU fluid resuscitation (Finfer, 2004, "A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit"), guiding choices amid coagulopathy and sepsis risks. These strategies impact intensive care units by optimizing massive transfusion protocols and minimizing complications like acute kidney injury linked to fluid choices.
Reading Guide
Where to Start
Start with "A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care" (Hébert et al., 1999) because it provides foundational evidence on restrictive versus liberal transfusion strategies in critical care, directly applicable to trauma resuscitation basics.
Key Papers Explained
Hébert et al. (1999) in "A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care" established restrictive transfusion efficacy, informing later trauma-specific work. Finfer (2004) in "A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit" extended this by showing fluid equivalence in ICU settings with coagulopathy risks. Williams-Johnson et al. (2010) in "Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial" built on hemostasis by demonstrating antifibrinolytic benefits. Holcomb et al. (2015) in "Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma" advanced ratios for massive transfusion, linking prior findings to trauma outcomes.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current work emphasizes thromboelastography-guided resuscitation and glycocalyx protection in coagulopathy, though no preprints are available. Integration with acute kidney injury guidelines like KDIGO persists, as in Khwaja (2012, "KDIGO Clinical Practice Guidelines for Acute Kidney Injury"), amid ongoing massive transfusion refinements.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Measuring inconsistency in meta-analyses | 2003 | BMJ | 60.5K | ✕ |
| 2 | KDIGO Clinical Practice Guidelines for Acute Kidney Injury | 2012 | Nephron Clinical Practice | 7.6K | ✕ |
| 3 | Acute Kidney Injury Network: report of an initiative to improv... | 2007 | Critical Care | 7.0K | ✓ |
| 4 | Intravenous Fluids and Acute Kidney Injury | 2017 | Blood Purification | 6.8K | ✓ |
| 5 | A Multicenter, Randomized, Controlled Clinical Trial of Transf... | 1999 | New England Journal of... | 5.2K | ✓ |
| 6 | Effects of tranexamic acid on death, vascular occlusive events... | 2010 | The Lancet | 3.2K | ✓ |
| 7 | A Comparison of Albumin and Saline for Fluid Resuscitation in ... | 2004 | New England Journal of... | 2.8K | ✓ |
| 8 | Diagnosis, evaluation, and management of acute kidney injury: ... | 2013 | Critical Care | 2.6K | ✓ |
| 9 | Acute kidney injury | 2012 | The Lancet | 2.5K | ✕ |
| 10 | Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1... | 2015 | JAMA | 2.4K | ✓ |
Frequently Asked Questions
What is the effect of tranexamic acid in trauma patients with hemorrhage?
Tranexamic acid reduces death, vascular occlusive events, and blood transfusion requirements in trauma patients with significant haemorrhage. This was demonstrated in the CRASH-2 randomised, placebo-controlled trial (Williams-Johnson et al., 2010, "Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial"). The intervention targets coagulopathy in acute bleeding scenarios.
How do albumin and saline compare in ICU fluid resuscitation?
Use of 4 percent albumin or normal saline for fluid resuscitation in ICU patients results in similar outcomes at 28 days. This equivalence holds across critically ill populations requiring volume replacement (Finfer, 2004, "A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit"). Selection depends on context like coagulopathy or sepsis.
What transfusion ratio is used in severe trauma?
A 1:1:1 ratio of plasma, platelets, and red blood cells is applied in severe trauma resuscitation, associated with lower mortality at 24 hours (9.2%) and 30 days (21.2%) versus 1:1:2 ratios. Results come from the PROPPR multicenter trial (Holcomb et al., 2015, "Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma"). This addresses acute coagulopathy from massive transfusion.
What is a restrictive transfusion strategy in critical care?
A restrictive red-cell transfusion strategy is at least as effective as a liberal one in critically ill patients, possibly superior except in acute myocardial infarction or unstable angina. The approach was validated in a multicenter randomized trial (Hébert et al., 1999, "A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care"). It minimizes risks in coagulopathy management.
How does fluid choice relate to acute kidney injury?
Intravenous fluids influence acute kidney injury risk, with over 50% of body fluids dynamically regulated across compartments. Crystalloids and colloids like albumin require consideration of electrolyte and acid-base balance (Ding et al., 2017, "Intravenous Fluids and Acute Kidney Injury"). This ties to resuscitation in trauma and sepsis.
What role does thromboelastography play in coagulopathy?
Thromboelastography assesses coagulation status in trauma-induced coagulopathy, guiding hemostatic resuscitation. It evaluates whole blood clotting dynamics amid hemorrhage and massive transfusion needs. The method supports targeted therapy in critical care.
Open Research Questions
- ? How do optimal transfusion ratios vary in trauma patients with concurrent sepsis and coagulopathy?
- ? What is the precise impact of glycocalyx damage on hemostasis failure during resuscitation?
- ? Which fluid types best preserve kidney function in massive transfusion protocols?
- ? How does early tranexamic acid timing affect long-term outcomes beyond 30 days in hemorrhage?
- ? What biomarkers predict progression from trauma coagulopathy to multi-organ failure?
Recent Trends
The field maintains 44,052 works with steady focus on crystalloids versus albumin, balanced transfusions, and tranexamic acid, as no growth rate, recent preprints, or news coverage data indicate shifts.
PROPPR trial results from 2015 (Holcomb et al.) continue influencing protocols, alongside CRASH-2 on tranexamic acid.
2010Research Trauma, Hemostasis, Coagulopathy, Resuscitation with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Trauma, Hemostasis, Coagulopathy, Resuscitation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers